Ind-Swift Laboratories Limited Q1, Q2, Q3, Q4, FY 2017-18, FY 2016-17 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Ind-Swift Laboratories Limited Company Profile :

Ind-Swift Laboratories Limited is an India company engaged in the business of development of active pharmaceutical ingredients (APIs). The Company is engaged in the manufacture of pharmaceuticals. The Company operates in the bulk drugs and pharmaceuticals segment.

The Company has a product portfolio of approximately 50 products across approximately various therapeutic categories, such as macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsyhotic, bone resorption inhibitor, hyperparathyrodism, antineoplastic, treatment of premature ejaculation and nootropic, among others.


Ind-Swift Laboratories ResultsBSE Code : 532305
NSE Symbol : INDSWFTLAB
ISIN No. : INE915B01019
Industry : Pharmaceuticals
Face Value : Rs.10.00


If you are an investor who has shares of Ind-Swift Laboratories or you are an stock market analyst then i am sure you might for Quarterly Results of Ind-Swift Laboratories.

In this article you will find Q1, Q2, Q3, Q4 and FY 2017-18 Results of Ind-Swift Laboratories. That’s not all, you can compare those results with previous year i.e., FY 2016-17 Results of Ind-Swift Laboratories.

Ind-Swift Laboratories Q1 Results 2017-18 :

Ind-Swift Laboratories will announce its Q1 FY 2017-18 Results in August 2017. Will soon update the below mentioned table.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Ind-Swift Laboratories will announce its Q2 FY 2017-18 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Ind-Swift Laboratories will announce its Q3 FY 2017-18 Results in the month of January 2018.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Ind-Swift Laboratories will announce its Q4 FY 2017-18 Results in the month of April 2018.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Ind-Swift Laboratories will announce its FY 2017-18 Results in the month of April 2018.

(Values in Cr.) FY 2017-18 Standalone FY 2017-18 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Ind-Swift Laboratories Previous Year’s Results (FY 2016-17) :

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : If you like this information about Ind-Swift Laboratories Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.